title: Osteoclast formation from human cord blood mononuclear cells co-cultured with mice embryonic metatarsals in the presence of M-CSF.
abstract: Investigating the potentiality of cord monocytes to differentiate toward osteoclast-like cells (OCL) in vitro, we previously reported that in the presence of 1,25(OH)2 vitamin D3 (1,25-(OH)2D3), multinucleated-cells generated by cord monocyte cultures though displaying morphological features of OCL failed to resorb devitalized bones. We thus hypothesized that full differentiation of cord monocytes toward bone-resorbing cells may require the presence of factors released from and/or direct interactions with living osteogenic cells. In the present study, we tested these hypotheses using two culture systems supporting the development of bone-resorbing cells in the presence of bone matrix. First, cord mononuclear cells were co-cultured with murine fetal metatarsals depleted of osteoclast progenitor cells (stripped metatarsals) in the presence of 1,25-(OH)2D3. We found that cord mononuclear cells failed to differentiate toward OCL as indicated by the absence of the release of 45Ca previously incorporated in fetal bones and by the absence of formation of TRAP-positive (TRAP[+]) multinucleated cells which have invaded mineralized cartilage during the co-culture period. In the same model, we then investigated the effect of some soluble factors known as stimulators of osteoclast differentiation. Whereas exogenous rhIL6 and rhIL3 were ineffective in this assay, rhM-CSF consistently increased both the number of TRAP(+) multinucleated cells inside the mineralized cartilage and the release of 45Ca into the culture media. The effects of rhM-CSF were time-dependent reaching the maximum after 3 weeks of culture.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: INSERM U349, Biologie cellulaire et moléculaire de l'os et du cartilage, Centre Viggo Petersen, Hôpital Lariboisière, Paris, France.
authors.forename: G
authors.initials: G
authors.lastname: Mbalaviele
authors.forename: P
authors.initials: P
authors.lastname: Orcel
authors.forename: C
authors.initials: C
authors.lastname: Morieux
authors.forename: P J
authors.initials: PJ
authors.lastname: Nijweide
authors.forename: M C
authors.initials: MC
authors.lastname: de Vernejoul
mesh_terms: D000818:Animals; D002116:Calcitonin / Q000494:pharmacology; D002448:Cell Adhesion / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects; D002478:Cells, Cultured; D004622:Embryo, Mammalian / Q000166:cytology / Q000187:drug effects; D005314:Embryonic and Fetal Development / Q000187:drug effects; D005312:Fetal Blood / Q000166:cytology*; D006651:Histocytochemistry; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000166:cytology / Q000187:drug effects*; D016173:Macrophage Colony-Stimulating Factor / Q000494:pharmacology*; D008682:Metatarsal Bones / Q000166:cytology / Q000187:drug effects* / Q000196:embryology; D051379:Mice; D010010:Osteoclasts / Q000166:cytology / Q000187:drug effects*
chemical_list: C028815:salmon calcitonin; D016173:Macrophage Colony-Stimulating Factor; D002116:Calcitonin